TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel Biotech company Tissue Repair Ltd (ASX:TRP) has seen its share price rise more than 30% on news it had gained TGA (Therapeutic Goods Administration) approval for its advanced wound healing gel TR Pro+, which contains yeast-derived active ingredient Glucoprime.At 13:25 AEDT, shares in Tissue Repai... Caroline Smith 2 days ago ASX News Healthcare Biotechnology
LGP Little Green Pharma (ASX:LGP) reports revenue increase in Q4 FY24 This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in ... Sean Boss 3 days ago ASX News Healthcare
HXL Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment Hexima Ltd has seen a strong rise in share price after it told the market of a proposal to takeover Real Thing Entertainment Pty Ltd. Caroline Smith 3 days ago ASX News Consumer Cyclical Healthcare Technology Media - Diversified Biotechnology AI
OPL Opyl forms JV with UK and US consortium to bring products to the world Medical technology and AI company Opyl Ltd is set to form a joint venture with UK and US consortium Xco to market its products. Caroline Smith 3 days ago ASX News Healthcare Technology Software - Application
EMV EMVision Medical successfully fabs first prototype of First Responder brain scan device – portable enough for a backpack EMVision Medical Devices (ASX:EMV) has announced its successful fabrication of a portable on-the-spot brain scanning device. Jonathon Davidson 4 days ago ASX News Healthcare Medical Devices
HBF to throw 10% vote behind NDC BidCo's buyout of Pacific Smiles Group Pacific Smiles Group has confirmed 10% shareholder HBF – the private health insurer – will vote in favour of PSQ's buyout by NDC BidCo. Jonathon Davidson 5 days ago ASX News Healthcare
AGH Althea Group inks 'JV agreements' to boost marketing of cannabis-based beverage product in US market Althea Group (ASX:AGH) has inked agreements "to establish [a] joint venture" with Flora Growth Corporation to make cannabis-based beverages. Jonathon Davidson 5 days ago ASX News Consumer Cyclical Healthcare
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ Imricor Medical Systems Ltd intends to use the capital raising's funds to support a three-pronged growth strategy. Caroline Smith 19 Jul 2024 12:45 (AEST) ASX News Healthcare Medical Devices
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board HITIQ (ASX:HIQ) has announced its sensor-containing Nexus mouthguard meets World Rugby's specifications for the safety products. Jonathon Davidson 18 Jul 2024 11:36 (AEST) ASX News Healthcare Technology Medical Devices
ATH Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability An interim trial testing the effects of ATH434 on patients with MSA has yielded positive results for Alterity. Caroline Smith 17 Jul 2024 11:45 (AEST) ASX News Healthcare Biotechnology
RCE Recce scores US$2M deal from US Department of Defense for burn wound infections gel Recce Pharmaceuticals Ltd has been funded to the tune of US$2M by the US Department of Defense to develop its R327G gel. Caroline Smith 15 Jul 2024 11:28 (AEST) ASX News Healthcare
IMM Immutep reports strong response rate from immunotherapies treating carcinomas Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs. Caroline Smith 12 Jul 2024 10:03 (AEST) ASX News Healthcare Biotechnology
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system. Jonathon Davidson 11 Jul 2024 13:29 (AEST) ASX News Healthcare Biotechnology